Potential protective associations of antidiabetic and lipid-lowering therapies with retinal vein occlusion risk: a systematic review and meta-analysis.

چکیده

Retinal vein occlusion (RVO) shares key pathophysiological pathways with metabolic and atherothrombotic disorders. Emerging evidence suggests that statins and antidiabetic drugs may be associated with lower RVO incidence, yet their potential to modify RVO risk remains uncertain. A systematic search…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• شبکیه